Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_2:p11
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 2 (pt 11/13)
Character Range: 17504601–17507853

be authorised where a patient's weight is greater than 125 kg
V15820          Trastuzumab                Increased maximum amounts may only be authorised where a patient's weight is greater than 125 kg
V15826          Trastuzumab deruxtecan     Increased maximum amounts may only be authorised where a patient's weight is greater than 125 kg
V15827          Trastuzumab emtansine      Increased maximum amounts may only be authorised where a patient's weight is greater than 125 kg
V15828          Trastuzumab emtansine      Increased maximum amounts may only be authorised where a patient's weight is greater than 125 kg
V15831          Trastuzumab                Increased maximum amounts may only be authorised where a patient's weight is greater than 125 kg
V15832          Trastuzumab deruxtecan     Increased maximum amounts may only be authorised where a patient's weight is greater than 125 kg
V15994          Fentanyl                   Authorities for increased maximum quantities and/or repeats must only be considered for chronic severe disabling pain where the total duration of non-PBS and PBS opioid analgesic treatment: (i) exceeds 12 months and the palliative care patient is unable to have annual pain management review due to their clinical condition; or (ii) exceeds 12 months and the patient's clinical need for continuing opioid treatment has been confirmed through consultation with the patient by another medical practitioner or a palliative care nurse practitioner in the past 12 months; or (iii) has exceeded 12 months prior to 1 June 2020 and the patient's clinical need for continuing opioid treatment has not been confirmed through consultation with the patient by another medical practitioner or a palliative care nurse practitioner in the past 12 months, but is planned in the next 3 months.
                Methadone                  Authority requests extending treatment duration up to 1 month may be requested through the Online PBS Authorities system or by calling Services Australia.
                                           Authority requests extending treatment duration beyond 1 month may be requested through the Online PBS Authorities system or in writing and must not provide a treatment duration exceeding 3 months (quantity sufficient for up to 1 month treatment and sufficient repeats).
V15996          Fentanyl                   Authorities for increased maximum quantities and/or repeats under this restriction must only be considered for chronic severe disabling pain where the total duration of non-PBS and PBS opioid analgesic treatment is less than 12 months.
                Methadone                  Authority requests extending treatment duration up to 1 month may be requested through the Online PBS Authorities system or by calling Services Australia. Authority requests extending treatment duration beyond 1 month may be requested through the Online PBS Authorities system or in writing and must not provide a treatment duration exceeding 3 months (quantity sufficient for up to 1 month treatment and sufficient repeats).
V16000          Fentanyl                   Authorities for increased maximum quantities and/or repeats must only be considered for chronic severe disabling pain where the